NEW YORK (GenomeWeb News) – Oxford Gene Technology has licensed the rights to make and market certain oligonucleotide microarrays using the company’s Southern array patents to BF-BIOlabs, OGT said today.
 
Under the license, BF-BIOlabs will be able to sell arrays and array-based services for identifying genes, SNPs, and gene expression analysis.
 
OGT said the license will remain valid for the lifetime of the patents. Financial terms of the agreement were not released.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.